The inhibition of IL-17 has been demonstrated to ameliorate the lipopolysaccharide (LPS) exacerbated asthma in murine models [9,10,11,12] and, at the same time, to exert protective effects on LPS-induced ALI in mice [13]. Here, IL17A is linked to asthma.